Outpatient systemic antimycotic and antifungal use in Europe: New outcome measure provides new insight

International Journal of Antimicrobial Agents

Volumn 42, Issue 5, 2013, Pages 466-470

  Adriaenssens, Niels ^a   Coenen, Samuel ^a   Versporten, Ann ^a   Goossens, Herman ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Ambulatory care; Antifungal agents; Antimycotic use; Drug consumption; Pharmacoepidemiology

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; TERBINAFINE;

ANTIFUNGAL RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BELGIUM; CONTROLLED STUDY; DRUG PACKAGING; DRUG USE; EUROPE; GREECE; HUMAN; MYCOSIS; OUTCOME ASSESSMENT; OUTPATIENT CARE; PRIORITY JOURNAL; ROMANIA; SWEDEN;

AMBULATORY CARE; ANTIFUNGAL AGENTS; ANTIMYCOTIC USE; DRUG CONSUMPTION; PHARMACOEPIDEMIOLOGY;

ANTIFUNGAL AGENTS; DRUG UTILIZATION; EUROPE; HUMANS; MYCOSES; OUTCOME ASSESSMENT (HEALTH CARE); OUTPATIENTS;

EID: 84885419303     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.07.004     Document Type: Article

References (16)

1. R. Vander Stichele, M. Elseviers, M. Ferech, S. Blot, H. Goossens ESAC Project Group European Surveillance of Antimicrobial Consumption (ESAC): data collection performance and methodological approach Br J Clin Pharmacol 58 2004 419 428
2. N. Adriaenssens, S. Coenen, A. Versporten, A. Muller, G. Minalu, and C. Faes European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009) J Antimicrob Chemother 66 2011 vi3 vi12
3. N. Adriaenssens, S. Coenen, A. Muller, V. Vankerckhoven, H. Goossens ESAC Project Group European Surveillance of Antimicrobial Consumption (ESAC): outpatient systemic antimycotic and antifungal use in Europe J Antimicrob Chemother 65 2010 769 774
4. N. Adriaenssens, S. Coenen, A. Versporten, A. Muller, G. Minalu, and C. Faes European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009) J Antimicrob Chemother 66 2011 vi37 vi45
5. N. Adriaenssens, S. Coenen, A. Versporten, A. Muller, G. Minalu, and C. Faes European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009) J Antimicrob Chemother 66 2011 vi47 vi56
6. A. Versporten, S. Coenen, N. Adriaenssens, A. Muller, G. Minalu, and C. Faes European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009) J Antimicrob Chemother 66 2011 vi25 vi35
7. A. Versporten, S. Coenen, N. Adriaenssens, A. Muller, G. Minalu, and C. Faes European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997-2009) J Antimicrob Chemother 66 2011 vi13 vi23
8. S. Coenen, N. Adriaenssens, A. Versporten, A. Muller, G. Minalu, and C. Faes European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997-2009) J Antimicrob Chemother 66 2011 vi57 vi70
9. G. Minalu, M. Aerts, S. Coenen, A. Versporten, A. Muller, and N. Adriaenssens Application of mixed-effects models to study the country-specific outpatient antibiotic use in Europe: a tutorial on longitudinal data analysis J Antimicrob Chemother 66 2011 vi79 vi87
10. C. Faes, G. Molenberghs, N. Hens, A. Muller, H. Goossens, and S. Coenen Analysing the composition of outpatient antibiotic use: a tutorial on compositional data analysis J Antimicrob Chemother 66 2011 vi89 vi94
11. N. Adriaenssens, S. Coenen, A. Versporten, A. Muller, V. Vankerckhoven, and H. Goossens European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of outpatient antibiotic use in Europe J Antimicrob Chemother 66 2011 vi71 vi77
12. WHO Collaborating Centre for Drug Statistics Methodology Guidelines for ATC classification and DDD assignment 2011 2010 WHO Collaborating Centre for Drug Statistics Methodology Oslo, Norway www.whocc.no/filearchive/publications/ 2011guidelines.pdf (accessed 29. 07. 2013)
13. European Surveillance of Antimicrobial Consumption (ESAC) Management Team, ESAC Scientific Advisory Board and ESAC National Networks. ESAC yearbook 2009. Antwerp, Belgium: University of Antwerp, 2011. http://www.esac.ua.ac.be/ main.aspx?c=*ESAC2&n=50036 (accessed 28.05.2013).
14. S. Blot, R. Janssens, G. Claeys, E. Hoste, F. Buyle, and J.J. De Waele Effect of fluconazole consumption on long-term trends in candidal ecology J Antimicrob Chemother 58 2006 474 477
15. L. Ostrosky-Zeichner, J.H. Rex, P.G. Pappas, R.J. Hamill, R.A. Larsen, and H.W. Horowitz Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States Antimicrob Agents Chemother 47 2003 3149 3154
16. L.P. Brion, S.E. Uko, and D.L. Goldman Risk of resistance associated with fluconazole prophylaxis: systematic review J Infect 54 2007 521 529